Li et al. confirmed that ANCR participated in TGF-β1-induced EMT and TGF-β1 could down-regulate ANCR expression by increasing HDAC3 enrichment at ANCR promoter region, which decrease both H3 and H4 acetylation of ANCR promoter in breast cancer. This evidence concerns the gene TGFB1 and breast carcinoma.